Overview
STRO market data
Price History
STRO price chart · 1M
- O
- 21.06
- H
- 21.66
- L
- 21.06
- C
- 21.23
- Vol
- 6,881.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $21.06
- Previous Close
- $21.35
- Day High
- $21.66
- Day Low
- $21.06
- 52 Week High
- $42.39
- 52 Week Low
- $18.41
- 7 Day Return
- +0.02%
- 30 Day Return
- -10.44%
- 90 Day Return
- -26.68%
- 1 Year Return
- -40.23%
- Daily Notional Volume
- $146.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$22.49 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.47 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -154.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.15 – $43.85 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $360.1M · P/B 3.40 · P/S 3.61.
Company News
Citizens Maintains Market Outperform on Sutro Biopharma, Lowers Price Target to $34Benzinga · Aug 13, 2026, 2:01 PM
Wedbush Reiterates Outperform on Sutro Biopharma, Maintains $60 Price TargetBenzinga · Aug 13, 2026, 12:54 PM
Why is Sutro Biopharma Stock Falling On Wednesday?Benzinga · Aug 12, 2026, 6:04 PM
Gold Gains 1%; Performance Food Group Shares Fall After Q4 ResultsBenzinga · Aug 12, 2026, 4:16 PM
Sutro Biopharma shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 12, 2026, 2:19 PM
8-K filing — SUTRO BIOPHARMA, INC. (STRO)SEC EDGAR · Aug 12, 2026, 11:15 AM
Sutro Biopharma Q2 EPS $(2.33) Misses $(2.19) Estimate, Sales $9.839M Miss $13.048M EstimateBenzinga · Aug 12, 2026, 11:02 AM
Truist Securities Assumes Sutro Biopharma at Buy, Announces Price Target of $50Benzinga · Jun 11, 2026, 12:46 PM
Barclays Initiates Coverage On Sutro Biopharma with Overweight Rating, Announces Price Target of $56Benzinga · May 28, 2026, 1:45 PM